Netherlands: Market for Other Medicaments For Therapeutic Or Prophylactic Uses 2025

Market Size for Other Medicaments For Therapeutic Or Prophylactic Uses in the Netherlands

The Dutch market for other medicaments for therapeutic or prophylactic uses dropped to $X in 2022, which is down by X% against the previous year. Over the period under review, consumption continues to indicate noticeable growth. Over the period under review, the market hit record highs at $X in 2018; however, from 2019 to 2022, consumption remained at a lower figure.

Production of Other Medicaments For Therapeutic Or Prophylactic Uses in the Netherlands

In value terms, production of other medicaments for therapeutic or prophylactic uses contracted to $X in 2022 estimated in export price. In general, production continues to indicate a deep contraction. The pace of growth appeared the most rapid in 2018 when the production volume increased by X% against the previous year. Over the period under review, production of hit record highs at $X in 2020; however, from 2021 to 2022, production remained at a lower figure.

Exports of Other Medicaments For Therapeutic Or Prophylactic Uses

Exports from the Netherlands

In 2022, exports of other medicaments for therapeutic or prophylactic uses from the Netherlands soared to X tons, jumping by X% compared with the previous year. Over the period under review, exports showed a mild expansion. The growth pace was the most rapid in 2020 when exports increased by X%. As a result, the exports attained the peak of X tons. From 2021 to 2022, the growth of the exports of failed to regain momentum.

In value terms, exports of other medicaments for therapeutic or prophylactic uses reduced slightly to $X in 2022. In general, exports enjoyed a perceptible expansion. The pace of growth appeared the most rapid in 2020 when exports increased by X%. As a result, the exports attained the peak of $X. From 2021 to 2022, the growth of the exports of failed to regain momentum.

Exports by Country

Russia (X tons) was the main destination for exports of other medicaments for therapeutic or prophylactic uses from the Netherlands, accounting for a X% share of total exports. Moreover, exports of other medicaments for therapeutic or prophylactic uses to Russia exceeded the volume sent to the second major destination, China (X tons), twofold. The third position in this ranking was held by Germany (X tons), with a X% share.

From 2012 to 2022, the average annual rate of growth in terms of volume to Russia stood at X%. Exports to the other major destinations recorded the following average annual rates of exports growth: China (X% per year) and Germany (X% per year).

In value terms, Russia ($X) emerged as the key foreign market for other medicaments for therapeutic or prophylactic uses exports from the Netherlands, comprising X% of total exports. The second position in the ranking was taken by China ($X), with a X% share of total exports. It was followed by Belgium, with a X% share.

From 2012 to 2022, the average annual rate of growth in terms of value to Russia totaled X%. Exports to the other major destinations recorded the following average annual rates of exports growth: China (X% per year) and Belgium (X% per year).

Export Prices by Country

In 2022, the average export price for other medicaments for therapeutic or prophylactic uses amounted to $X per ton, shrinking by X% against the previous year. In general, the export price, however, recorded a relatively flat trend pattern. The pace of growth was the most pronounced in 2017 when the average export price increased by X% against the previous year. Over the period under review, the average export prices reached the peak figure at $X per ton in 2020; however, from 2021 to 2022, the export prices stood at a somewhat lower figure.

Prices varied noticeably by country of destination: amid the top suppliers, the country with the highest price was Belgium ($X per ton), while the average price for exports to Germany ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was recorded for supplies to South Korea (X%), while the prices for the other major destinations experienced more modest paces of growth.

Imports of Other Medicaments For Therapeutic Or Prophylactic Uses

Imports into the Netherlands

In 2022, imports of other medicaments for therapeutic or prophylactic uses into the Netherlands soared to X tons, increasing by X% against 2021 figures. In general, imports, however, showed a noticeable decline. The pace of growth was the most pronounced in 2020 when imports increased by X% against the previous year. As a result, imports reached the peak of X tons. From 2021 to 2022, the growth of imports of remained at a lower figure.

In value terms, imports of other medicaments for therapeutic or prophylactic uses contracted rapidly to $X in 2022. Over the period under review, imports saw a strong expansion. The growth pace was the most rapid in 2020 when imports increased by X%. As a result, imports reached the peak of $X. From 2021 to 2022, the growth of imports of remained at a somewhat lower figure.

Imports by Country

Ireland (X tons), Germany (X tons) and Belgium (X tons) were the main suppliers of imports of other medicaments for therapeutic or prophylactic uses to the Netherlands, together accounting for X% of total imports. The United States, Canada, Romania, Hungary, Australia, Sweden and Israel lagged somewhat behind, together comprising a further X%.

From 2012 to 2022, the biggest increases were recorded for Australia (with a CAGR of X%), while purchases for the other leaders experienced more modest paces of growth.

In value terms, Ireland ($X), the United States ($X) and Germany ($X) were the largest other medicaments for therapeutic or prophylactic uses suppliers to the Netherlands, together comprising X% of total imports. Belgium, Hungary, Canada, Sweden, Australia, Romania and Israel lagged somewhat behind, together comprising a further X%.

Australia, with a CAGR of X%, recorded the highest rates of growth with regard to the value of imports, in terms of the main suppliers over the period under review, while purchases for the other leaders experienced more modest paces of growth.

Import Prices by Country

The average import price for other medicaments for therapeutic or prophylactic uses stood at $X per ton in 2022, declining by X% against the previous year. In general, the import price, however, saw a strong increase. The most prominent rate of growth was recorded in 2017 an increase of X%. Over the period under review, average import prices reached the maximum at $X per ton in 2018; however, from 2019 to 2022, import prices failed to regain momentum.

Prices varied noticeably by country of origin: amid the top importers, the country with the highest price was Israel ($X per ton), while the price for Romania ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Canada (X%), while the prices for the other major suppliers experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :